Clinical Trial Update: Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study

View source ↗

Summary

A completed medico-economic study evaluating the use of Synvisc (hylan G-F 20) for knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Status: COMPLETED